Contribution of tumour and immune cells to <scp>PD‐L1</scp> expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from <scp>KEYNOTE</scp> ‐119

Javier Cortes, Eric P Winer, Oleg Lipatov, Seock‐Ah Im, Anthony Gonçalves, Eva Muñoz‐Couselo, Keun Seok Lee, Peter Schmid, Kenji Tamura, Laura Testa, Isabell Witzel, Shoichiro Ohtani, Stephanie Hund, Karina Kulangara, Vassiliki Karantza, Jaime A Mejia, Junshui Ma, Petar Jelinic, Lingkang Huang, Scott K Pruitt, Kenneth Emancipator

Open source

DOI
10.1002/2056-4538.12371
Published
2024-04-16
Container
The Journal of Pathology: Clinical Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/2056-4538.12371,
  title = {Contribution of tumour and immune cells to
                    <scp>PD‐L1</scp>
                    expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from
                    <scp>KEYNOTE</scp>
                    ‐119},
  author = {Javier Cortes and Eric P Winer and Oleg Lipatov and Seock‐Ah Im and Anthony Gonçalves and Eva Muñoz‐Couselo and Keun Seok Lee and Peter Schmid and Kenji Tamura and Laura Testa and Isabell Witzel and Shoichiro Ohtani and Stephanie Hund and Karina Kulangara and Vassiliki Karantza and Jaime A Mejia and Junshui Ma and Petar Jelinic and Lingkang Huang and Scott K Pruitt and Kenneth Emancipator},
  year = {2024},
  journal = {The Journal of Pathology: Clinical Research},
  doi = {10.1002/2056-4538.12371},
  url = {https://doi.org/10.1002/2056-4538.12371}
}

RIS

TY  - JOUR
TI  - Contribution of tumour and immune cells to
                    <scp>PD‐L1</scp>
                    expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from
                    <scp>KEYNOTE</scp>
                    ‐119
AU  - Javier Cortes
AU  - Eric P Winer
AU  - Oleg Lipatov
AU  - Seock‐Ah Im
AU  - Anthony Gonçalves
AU  - Eva Muñoz‐Couselo
AU  - Keun Seok Lee
AU  - Peter Schmid
AU  - Kenji Tamura
AU  - Laura Testa
AU  - Isabell Witzel
AU  - Shoichiro Ohtani
AU  - Stephanie Hund
AU  - Karina Kulangara
AU  - Vassiliki Karantza
AU  - Jaime A Mejia
AU  - Junshui Ma
AU  - Petar Jelinic
AU  - Lingkang Huang
AU  - Scott K Pruitt
AU  - Kenneth Emancipator
PY  - 2024
JO  - The Journal of Pathology: Clinical Research
DO  - 10.1002/2056-4538.12371
UR  - https://doi.org/10.1002/2056-4538.12371
ER  - 

APA

Cortes, J., Winer, E. P., Lipatov, O., Im, S., Gonçalves, A., Muñoz‐Couselo, E., Lee, K. S., Schmid, P., Tamura, K., Testa, L., Witzel, I., Ohtani, S., Hund, S., Kulangara, K., Karantza, V., Mejia, J. A., Ma, J., Jelinic, P., Huang, L., Pruitt, S. K., & Emancipator, K. (2024). Contribution of tumour and immune cells to <scp>PD‐L1</scp> expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from <scp>KEYNOTE</scp> ‐119. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.12371

Source records